Article

Value-Based Insurance Plans Can Up Rx Adherence

Value-based insurance design (VBID) plans with certain features aside from solely lowering cost sharing can increase medication adherence, according to a study.

Health Affairs

Value-based insurance design (VBID) plans with certain features aside from solely lowering cost sharing can increase medication adherence, according to a study published in the March issue of .

Niteesh K. Choudhry, M.D., Ph.D., from Harvard University in Boston, and colleagues evaluated 76 VBID plans introduced by a large pharmacy benefit manager from 2007 to 2010.

The researchers found that VBID plans that made a significantly greater impact on adherence were more generous, targeted high-risk patients, offered wellness programs, did not offer disease management programs, and made the benefit available only for medication ordered by mail. The effects of these features were as large as four to five percentage points, compared to plans without these characteristics.

Read the full story here:http://bit.ly/1hPzT7v

Source: Doctor's Lounge

Related Videos
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Dr Margrit Wiesendanger
John Barkett, MBA
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
4 experts are featured in this series.
5 experts in this video
4 experts are featured in this series.
5 experts in this video
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Eboni Price-Haywood, MD, and Toni Flowers, PhD
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo